News

Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...
The imaging agent called Cytalux works by having patients receive an infusion before surgery that causes cancerous cells to glow like neon highlighter under infrared light.
Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...
With the progress in cancer treatments, we are increasingly achieving complete remission (CR) in more patients. Traditionally, CR has been defined as either a clinical CR, where symptoms and physical ...
Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in ...